Get started
Author

Catherine Nester

Observed institution: Inozyme Pharma (United States)
ORCID: 0000-0003-0851-2150
Observed ORCID: 0000-0003-0851-2150
OpenAlex ID: A5082875058
Musculoskeletal Comorbidities and Quality of Life in ENPP1-Deficient Adults and the Response of Enthesopathy to Enzyme Replacement Therapy in Murine Models
2020 · Carlos R. Ferreira, Anenya Jai Ansh, et al. · Journal of Bone and Mineral Research · 22
PDF
ENPP1 deficiency: A clinical update on the relevance of individual variants using a locus‐specific patient database
2022 · Stephanie A. Mercurio, Lauren M. Chunn, et al. · Human Mutation · 20
Lifelong impact of ENPP1 Deficiency and the early onset form of ABCC6 Deficiency from patient or caregiver perspective
2022 · Christine O’Brien, Gus Khursigara, et al. · PLoS ONE · 5
PDF
Response of enthesopathy in ENPP1 deficiency to enzyme replacement therapy in murine models and enthesopathy comorbidities and quality of life in ENPP1‐deficient adults
2022 · Anenya J. Ansh, Catherine Nester, et al. · The FASEB Journal
Author response for "Musculoskeletal comorbidities and quality of life in ENPP1 ‐deficient adults and the response of enthesopathy to enzyme replacement therapy in murine models"
2021 · Carlos R. Ferreira, Jain Ansh, et al. · Publons reviews and discussion
Abstract #1003877: The Lifelong Impact of ENPP1 Deficiency: Outcomes From a Patient and Caregiver Survey
2021 · Christine O'Brien, Beth Leiro, et al. · Endocrine Practice
From the voice of patients and caregivers: burden of illness in infantile onset ABCC6 and ENPP1 deficiency (GACI and ARHR2)
2021 · Christine O’Brien, Beth Leiro, et al. · Molecular Genetics and Metabolism
From the voice of patients and caregivers: Burden of illness in infantile onset ABCC6 and ENPP1 deficiency (GACI and ARHR2)
2021 · Christine O'Brien, Beth Leiro, et al. · Bone Reports
PDF
Works count: 8
Citation count: 47
H-index: 3
I10-index: 2
Year
Topic
Type